Showing results (371-380 of 385) with videos related to

Sort By:
Pageof 39
The Journal of Pathology. Clinical Research|March 8, 2022
The impact of whole genome and transcriptome analysis (WGTA) on predictive biomarker discovery and diagnostic accuracy of advanced malignanciesBasile Tessier-Cloutier, Jasleen K Grewal, Martin R Jones, et al.
The New England Journal of Medicine|December 23, 2011
Recurrent somatic DICER1 mutations in nonepithelial ovarian cancersAlireza Heravi-Moussavi, Michael S Anglesio, S-W Grace Cheng, et al.
Nature|June 12, 2024
Obesity induces PD-1 on macrophages to suppress anti-tumour immunityJackie E Bader, Melissa M Wolf, Gian Luca Lupica-Tondo, et al.
Signal Transduction and Targeted Therapy|June 3, 2026
Epigenetic control of telomeric RNA maintains heterochromatin in telomerase-driven cancersJared D W Price, Frederick S Vizeacoumar, Omar Abuhussein, et al.
Cell Genomics|May 10, 2025
Identification of targetable vulnerabilities of PLK1-overexpressing cancers by synthetic dosage lethalityChelsea E Cunningham, Frederick S Vizeacoumar, Yue Zhang, et al.
The Journal of Pathology|December 13, 2021
Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8+ TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomasKarolin Heinze, Tayyebeh M Nazeran, Sandra Lee, et al.
British Journal of Cancer|November 3, 2022
Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium StudyAshley Weir, Eun-Young Kang, Nicola S Meagher, et al.
Medrxiv : the Preprint Server for Health Sciences|November 21, 2023
Concurrent RB1 loss and BRCA-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinomaFlurina A M Saner, Kazuaki Takahashi, Timothy Budden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2024
Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous CarcinomaFlurina A M Saner, Kazuaki Takahashi, Timothy Budden, et al.
The Journal of Pathology. Clinical Research|March 22, 2023
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium studyMartin Köbel, Eun-Young Kang, Ashley Weir, et al.
Pageof 39